Full text is available at the source.
Abstract
Psilocybin-assisted therapy may provide rapid antidepressant effects in patients with cancer.
- Current trials have largely excluded patients undergoing active systemic anticancer treatment.
- Safety data for psilocybin-assisted therapy in this population remains limited.
- The findings suggest potential benefits for addressing depression in cancer patients.
Simplified